Interventional Glaucoma

Lower systolic perfusion pressure, lower systolic blood pressure and cardiovascular disease history are all predictors of glaucoma.

In patients with advanced visual field loss undergoing trabeculectomy with mitomycin C, there is a risk of severe loss of central vision.

In patients with open-angle glaucoma (OAG), the increase in intraocular pressure (IOP) caused by pharmacological pupillary dilation is related to the likelihood of future progression of glaucoma.

A gap analysis approach may be preferable to Kaplan-Meier survival curves for analysing patient persistence with prescribed medications.

The Visual Impairment Instrument (IVI) and the Glaucoma Symptom Scale (GSS) are suboptimal scales for assessing patients with glaucoma but relatively good vision.

Central corneal thickness (CCT) measurements should be included as part of a complete ocular examination, particularly in patients at risk of developing primary open angle glaucoma (POAG), according to a study conducted by the American Academy of Ophthalmology and published in the journal Ophthalmology.

Heidelberg Engineering premiered its new perimeter technology at this year's World Glaucoma Congress in Singapore.

The Ministry of Health, Labour and Welfare in Japan has approved Alcon's treatment for glaucoma and ocular hypertension, TRAVATANZ 0.004%.

The World Glaucoma Association has announced consensus findings that further determine the role of intraocular pressure (IOP) in glaucoma.

The Ex-PRESS implant appears to be as effective as trabeculectomy, furthermore it reduces postoperative compliance issues and seems to be safer, according to a paper presented at this year's World Glaucoma Congress held in Singapore.

Israeli firm IOPtima has completed development of its novel laser-based therapy for the treatment of glaucoma, OT134.

Drugs which slow the progress of Alzheimer's disease may also protect patients at risk of eye damage from glaucoma.

Madhu Nagar reviews some of the studies that support SLT's place as a first-line therapeutic in the treatment of glaucoma.

Ellex has launched a website that is to become the primary online resource for the company's selective laser trabeculoplasty (SLT) users.

The FDA has approved an import license application for the iCare tonometer, produced by Finnish firm Tiolat Oy.

A unique nanoparticle has been developed that could prove to be an effective drug delivery device for the treatment of glaucoma.

A 3-D computer automated threshold Amsler grid test is able to identify abnormalities characteristic of glaucoma in glaucoma suspects whose achromatic Humphrey visual field test was normal.

Community optometrists trained in glaucoma can provide satisfactory decisions regarding diagnosis and initiation of treatment.

High-tension open angle glaucoma (htOAG) is associated with high pulse pressure, increased carotid arterial stiffness and, in people treated for systemic hypertension, low diastolic perfusion pressure.

The practice of treating angle closure glaucoma (ACG) varies widely across the United Kingdom, according to a poster presented at the 8th congress of the European Glaucoma Society (EGS), held June 1–6 in Berlin.

Cup-to-disc ratios and visual field evaluations using telemedicine-friendly devices are the most useful tools for glaucoma screening.

In a systematic review of literature, Dr Donald Minckler reports on randomized, controlled trials of aqueous shunts and compares the success rates with those achieved by trabeculectomy.

Visual field screening is an indispensable tool and a prerequisite for proper disease management

Canaloplasty can offer a number of advantages over other techniques... by enhancing aqueous outflow without creating a bleb

In December 2006, the Swiss city of Geneva played host to the very first European glaucoma resident's course, designed for ophthalmic residents seeking the necessary skills for the diagnosis and therapy of glaucoma.